Evidence map›Paper›PMID 33320240›Full record

ArticleThe Journal of infectious diseases2021

Cerebrospinal Fluid and Plasma Lipopolysaccharide Levels in Human Immunodeficiency Virus Type 1 Infection and Associations With Inflammation, Blood-Brain Barrier Permeability, and Neuronal Injury.

Wei Jiang, Zhenwu Luo, Sophie Stephenson, Hong Li, Clara Di Germanio, Philip J Norris, Dietmar Fuchs, Henrik Zetterberg, Magnus Gisslen, Richard W Price

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

Wei JiangDepartment of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina, USA.
Zhenwu LuoDepartment of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina, USA.
Sophie StephensonDepartment of Neurology, University of California, San Francisco, San Francisco General Hospital, San Francisco, California, USA.
Hong LiPublic Health Sciences, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA.
Clara Di GermanioVitalant Research Institute, San Francisco, California, USA.
Philip J NorrisVitalant Research Institute, San Francisco, California, USA.
Dietmar FuchsInstitut für Biologische Chemie, Biozentrum, Medizinische Universität Innsbruck, Innsbruck, Austria.ORCID 0000-0003-1627-9563
Henrik ZetterbergDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden.ORCID 0000-0003-3930-4354
Magnus GisslenDepartment of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Richard W PriceDepartment of Neurology, University of California, San Francisco, San Francisco General Hospital, San Francisco, California, USA.
Medical University of South Carolina · USPacific Research Institute · USSahlgrenska University Hospital · SESan Francisco General Hospital · USInnsbruck Medical University · AT

Funding

Compartmentalized CSF viral escape and the CNS HIV reservoirR01NS094067 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PRICE, RICHARD W. · 2015 to 2020
$3.9M
On the pathogenic role of anti-CD4 antibody in poor CD4+ T cell recovery after antiretroviral therapy in HIV diseaseR01AI128864 · NIAID · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI JIANG, WEI · 2017 to 2021
$1.1M
European Research Council 681712NIAID NIH HHS R01 AI128864NINDS NIH HHS R01 NS094067
6 · The paper itself

Abstract

Human immunodeficiency virus (HIV) infection is associated with increased systemic microbial translocation, neuroinflammation, and occasionally, neuronal injury. Whether systemic lipopolysaccharide (LPS) penetrates into the brain and contributes to neuroinflammation remain unknown in HIV. Here, we measured plasma and cerebrospinal fluid (CSF) LPS levels along with biomarkers of neuroinflammation (white blood cell counts and 40 soluble markers) and neurofilament light chain (NfL). Notably, CSF LPS was undetectable in all samples, including 3 HIV-infected individuals with dementia. Increased plasma LPS, neuroinflammation, and blood-brain barrier (BBB) dysfunction were found in untreated HIV-infected individuals, but not in healthy or treated HIV-infected individuals. Plasma LPS levels were directly correlated with various markers of inflammation in both plasma and CSF, as well as with degree of BBB permeability but not with CSF NfL in HIV-infected subjects. These results suggest that the magnitude of microbial translocation associates with neuroinflammation and BBB permeability in HIV without direct penetration into the central nervous system.

Indexed as

Blood-Brain BarrierHIV InfectionsInflammationLipopolysaccharidesNeuroinflammatory DiseasesBiomarkersHIV-1HumansPermeabilityBiomarkersLipopolysaccharidesblood-brain barrier permeabilitycerebrospinal fluidHIV-1 infectionlipopolysaccharideneuroinflammationneuronal injury

Identifiers

PMID33320240
PMCPMC8136977
OpenAlexW3111006786

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.